Leivestad T, Thorsby E
Transplantation. 1984 Feb;37(2):175-81. doi: 10.1097/00007890-198402000-00012.
Fifteen recipients of donor-specific blood transfusions (DST) from HLA haploidentical related donors were tested for changes in immune responsiveness following the transfusions. Three patients developed cytotoxic antibodies toward the donor, but no "broad" sensitization toward the panel cells was seen. The responsiveness to mitogens (PHA and con A) and soluble antigens (PPD and a mixture of antigens) was not changed. MLC responsiveness toward the donor, but not to third-party or pool-stimulating cells, was reduced. Evidence of specific MLC-suppressing cells was found in 11 of 15 patients following DST. The cell-mediated lympholysis response toward the donor increased in 50% of the patients after DST, including those who developed antibodies. The frequency of acute rejection episodes in the 11 grafted patients was not correlated with the changes in in vitro responsiveness.
对15名接受来自HLA单倍型相同相关供体的供体特异性输血(DST)的受者,检测输血后免疫反应性的变化。3名患者产生了针对供体的细胞毒性抗体,但未观察到对一组细胞的“广泛”致敏。对丝裂原(PHA和Con A)和可溶性抗原(PPD和抗原混合物)的反应性未改变。对供体的混合淋巴细胞培养(MLC)反应性降低,但对第三方或汇集刺激细胞的反应性未降低。15名患者中有11名在接受DST后发现了特异性MLC抑制细胞的证据。DST后,50%的患者,包括那些产生抗体的患者,对供体的细胞介导淋巴细胞溶解反应增加。11名接受移植患者的急性排斥反应发生率与体外反应性的变化无关。